The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Open accessAbstract
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow. Although carbapenemase-producing Enterobacteriaceae have received the most attention because resistance was first reported in these pathogens in the early 1990s, there is increased awareness of the impact of carbapenem-resistant nonfermenting gram-negative bacteria, such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. Moreover, evaluating the problem of carbapenem resistance requires the consideration of both carbapenemase-producing bacteria as well as bacteria with other carbapenem resistance mechanisms. Advances in rapid diagnostic tests to improve the detection of carbapenem resistance and the use of large, population-based datasets to capture a greater proportion of carbapenem-resistant organisms can help us gain a better understanding of this urgent threat and enable physicians to select the most appropriate antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“Porins are nonspecific channels in the outer membrane of gram-negative bacteria that permit the passive transport of hydrophilic small molecules and nutrients (and also some antibiotics) across the otherwise impermeable membrane [30].”
BackgroundGlobal Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Self-citationUpdated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Poirel, L., & Dortet, L. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120355 · Cited by 761
Self-citationHow to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Carbapenem resistance: overview of the problem and future perspectives
Meletis, G. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115621709 · Cited by 725
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Self-citationGrundmann, H., Glasner, C., Albiger, B., Aanensen, D. M., Tomlinson, C. T., Andrasević, A. T., Cantón, R., Carmeli, Y., Friedrich, A. W., Giske, C. G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30257-2 · Cited by 662
Self-citationCarbapenemase-Producing Organisms: A Global Scourge
Bonomo, R. A., Burd, E. M., Conly, J., Limbago, B. M., Poirel, L., Segre, J. A., & Westblade, L. F. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix893 · Cited by 656
Self-citationvan Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Chang, Y.-T., Lin, C.-Y., Chen, Y.-H., & Hsueh, P.-R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00893 · Cited by 419
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 369
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
van Duin, D., Kaye, K. S., Neuner, E. A., & Bonomo, R. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.11.009 · Cited by 352
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Hsu, L.-Y., Apisarnthanarak, A., Khan, E., Suwantarat, N., Ghafur, A., & Tambyah, P. A. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-16 · Cited by 339
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
Self-citationThe Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection
Lutgring, J. D., & Limbago, B. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02771-15 · Cited by 272
Salimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., Robinson, G., Carroll, K. C., Greer, A., Morgan, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01679-15 · Cited by 243
Gales, A. C., Seifert, H., Gur, D., Castanheira, M., Jones, R. N., & Sader, H. S. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy293 · Cited by 220
Cai, B., Echols, R., Magee, G., Arjona Ferreira, J. C., Morgan, G., Ariyasu, M., Sawada, T., & Nagata, T. “. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx176 · Cited by 188
Strategies for identification of carbapenemase-producing Enterobacteriaceae
Nordmann, P., & Poirel, L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks426 · Cited by 184
Self-citation(2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.masthead.30-1 · Cited by 184
Ledeboer, N. A., Lopansri, B. K., Dhiman, N., Cavagnolo, R., Carroll, K. C., Granato, P., Thomson, R., Butler-Wu, S. M., Berger, H., Samuel, L., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00581-15 · Cited by 164
Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers
Poirel, L., & Nordmann, P. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00977-15 · Cited by 153
Self-citationPouch, S. M., & Satlin, M. J. (2016) · Virulence · doi:10.1080/21505594.2016.1213472 · Cited by 143
Findlay, J., Hopkins, K. L., Meunier, D., & Woodford, N. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku571 · Cited by 135
Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle
Gniadek, T. J., Carroll, K. C., & Simner, P. J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03264-15 · Cited by 128
Labarca, J. A., Salles, M. J. C., Seas, C., & Guzmán-Blanco, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.940494 · Cited by 118
Interaction of Avibactam with Class B Metallo-β-Lactamases
Abboud, M. I., Damblon, C., Brem, J., Smargiasso, N., Mercuri, P. S., Gilbert, B., Rydzik, A. M., Claridge, T. D. W., Schofield, C. J., & Frère, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00897-16 · Cited by 110
Banerjee, R., & Humphries, R. M. (2016) · Virulence · doi:10.1080/21505594.2016.1185577 · Cited by 107
McCann, E., Srinivasan, A., DeRyke, C. A., Ye, G., DePestel, D. D., Murray, J., & Gupta, V. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy241 · Cited by 106
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
Lee, C., & Doi, Y. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.3.149 · Cited by 104
Chakhtoura, N. G. E., Saade, E., Iovleva, A., Yasmin, M., Wilson, B. M., Pérez, F., & Bonomo, R. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1425139 · Cited by 100
Kiratisin, P., Chongthaleong, A., Tan, T. Y., Lagamayo, E., Roberts, S., Garcia, J., & Davies, T. A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.002 · Cited by 86
Polymyxin B Resistance in Carbapenem-ResistantKlebsiella pneumoniae, São Paulo, Brazil
Bartolleti, F., Seco, B. M. S., Santos, C. C., Felipe, C. B., Lemo, M. E. B., Alves, T. D. S., Passadore, L. F., Mimiça, M. J., Sampaio, S. C. F., Zavascki, A. P., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2210.160695 · Cited by 75
Andria, N., Henig, O., Kotler, O., Domchenko, A., Oren, I., Zuckerman, T., Ofran, Y., Fraser, D., & Paul, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv218 · Cited by 71
Mataseje, L. F., Abdesselam, K., Vachon, J., Mitchell, R., Bryce, E., Roscoe, D. L., Boyd, D. A., Embreé, J., Katz, K. C., Kibsey, P., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01359-16 · Cited by 70
Chea, N., Bulens, S. N., Kongphet-Tran, T., Lynfield, R., Shaw, K. M., Vagnone, P. S., Kainer, M. A., Muleta, D. B., Wilson, L. E., Vaeth, E., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2109.150198 · Cited by 67
Sader, H. S., Castanheira, M., Farrell, D. J., Flamm, R. K., Mendes, R. E., & Jones, R. N. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.021 · Cited by 60
Wendel, A., Kolbe-Busch, S., Ressina, S., Schulze‐Röbbecke, R., Kindgen‐Milles, D., Lorenz, C., Pfeffer, K., & MacKenzie, C. R. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.02.024 · Cited by 52
Cunningham, S. A., Vasoo, S. S., & Patel, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03302-15 · Cited by 34
Kostyanev, T., Vilken, T., Lammens, C., Timbermont, L., Veen, A. V. '., & Goossens, H. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.10.013 · Cited by 34
López-García, A., Rocha‐Gracia, R. D. C., Bello‐López, E., Juárez-Zelocualtecalt, C., Sáenz, Y., Castañeda, M., López-Pliego, L., González‐Vázquez, M. C., Torres, C., Ayala-Nuñez, T., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173455 · Cited by 28
Strateva, T., Sirakov, I. N., Stoeva, T., Stratev, A., Dimov, S., Savov, E., & Mitov, I. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.10.027 · Cited by 27
Kim, T., Lee, E. J., Park, S. Y., Yu, S. N., Lee, Y., Park, K., Park, S. Y., Jeon, M. H., Choo, E. J., Kim, T. H., et al. (2018) · Medicine · doi:10.1097/md.0000000000012984 · Cited by 21
Trends of 9,416 multidrug-resistant Gram-negative bacteria
Oliveira, V. D. C., Rubio, F. G., de Almeida, M. T. G., Nogueira, M. C. L., & Pignatari, A. C. C. (2015) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.61.03.244 · Cited by 18
Cited by
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Kyriakidis, I., Vasileiou, E., Pana, Z. D., & Tragiannidis, A. (2021) · Pathogens · doi:10.3390/pathogens10030373 · Cited by 678
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Jean, S.-S., Harnod, D., & Hsueh, P.-R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.823684 · Cited by 366
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Ma, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127249 · Cited by 308
Metadata
- Authors
- Nordmann, P., & Poirel, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-13
- Volume
- 69
- Issue
- Supplement_7
- Pages
- S521-S528
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2986744786
- Cited by
- 721
- References
- 51
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.